🇩🇪 Germany Country × Condition
mitral regurgitation Clinical Trials in Germany
Active clinical trials for mitral regurgitation with research sites in Germany. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇩🇪 Germany
Active Trials in Germany (4)
NCT04761120
Recruiting
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Enrollment
550 pts
Country
🇩🇪 Germany
Abbott Medical Devices
View Trial → NCT02033811
Recruiting
MitraClip® Registry
Enrollment
200 pts
Country
🇩🇪 Germany
Klinik für Kardiologie, Pneumologie...
View Trial → NCT06836011
Recruiting
A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, and Prognostic Impact.
Enrollment
600 pts
Country
🇩🇪 Germany
Medical University of Vienna
View Trial → NCT06634121
Recruiting
Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population
Enrollment
180 pts
Country
🇩🇪 Germany
LMU Klinikum
View Trial → Frequently Asked Questions
How many mitral regurgitation clinical trials are active in Germany?
There are currently 4 active clinical trials for mitral regurgitation with sites in Germany, of which 4 are actively recruiting patients.
How can I join a mitral regurgitation clinical trial in Germany?
To join a mitral regurgitation clinical trial in Germany, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Germany directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are mitral regurgitation trials in Germany?
Active mitral regurgitation trials in Germany span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology